Nominations Open for the 2022 Richard Lane/Robert Holden Advocacy Award!

Nominations Open for the 2022 Richard Lane/Robert Holden Advocacy Award!

Richard Lane was a long-term heroin user who, upon release from prison in 1967, was instrumental in establishing one of the Nation’s first opioid treatment programs. In 1974, he became the Executive Director of Man Alive and later served as Vice President of the American Methadone Treatment Association (now AATOD) and as Vice Chairman of the Governor’s Council on Alcohol and Drug Abuse in Maryland. Mr. Lane was a passionate advocate for methadone treatment (the only medication for opioid use disorder available at the time) and, by disclosing his own treatment experiences, provided inspiration to patients and colleagues alike.

Robert Holden was also a recovering heroin user, who later became the Director of PIDARC, an outpatient opioid treatment program in the District Of Columbia. He was a friend of Richard Lane and succeeded Richard Lane’s term of office as the Vice President of the American Association for the Treatment of Opioid Dependence (AATOD). This award was established in 1995 and recognizes extraordinary achievements in medication assisted treatment (MAT) patient advocacy.

The following criteria should be applied in making your selection:

  • Only one (1) nominee can be submitted by NAMA Recovery to the Conference Awards Committee. There may be a number of nominees however only one (1) “consensus” nominee may receive this honor.
  • The nominee must have been involved in the field of Medication Assisted Treatment (MAT) advocacy for a period of five (5) years.
  • The nominee must have made meaningful and consistent contributions, which have had a significant impact on opioid treatment within a state or region of the United States.
  • For each nominee a Nomination Form must be completed and submitted with two (2) Letters of Support.

NAMA Recovery will be responsible for collecting all the submissions for nomination and selecting a committee of advocates that will decide on the final candidate. The Candidate’s Name, Nomination Form and at least two (2) Letters of Support describing the nominee’s achievements will be submitted to the AATOD Conference Awards Committee for the final approval.

The deadline for submissions is Friday June 24, 2022, at 5:00pm Eastern Daylight Time.

The Nomination Form should be completed online HERE.

Two (2) or more Letters of Support should be sent via email to [email protected]

Previous Winners of the Award:

Richard Lane, 1995, Arizona
Joycelyn Woods, 2001, St. Louis
Anthony Scro, 2007, San Diego
Walter Ginter, 2009, New York
Lisa Mojer Torres, 2010, Chicago
Roxanne Baker, 2012, Las Vegas
Ira Marion, 2013, Philadelphia
Claude Hopkins, 2015, Atlanta
Brenda Davis, 2016, Baltimore
Paul Bowman, 2017 New York
Zachary Talbott, 2019 Orlando
Jana Burson, 2021 Las Vegas

This Award will be bestowed upon the recipient during the Awards Banquet Ceremony during the National AATOD Conference which will convene in Baltimore, Maryland in October.
The recipient will be provided with a roundtrip Coach Class airfare, up to two (2) nights in the hotel and Conference Registration.

Similar Posts

  • |

    Drug Court Fact Sheet

    Admin 01/29/2022

    Methadone Maintenance and Other Pharmacotherapeutic Interventions in the Treatment of Opioid Dependence. Overview Drug Courts are being confronted with increasing numbers of opiate dependent offenders. This Fact Sheet is intended to dispel misperceptions and educate practitioners about the efficacy of medication assisted treatment. Opioid dependence is a devastating reality and a treatable disease. According to…

  • The National Methadone Conference-1

    Admin 02/12/2023

    American Association for the Treatment of Opioid Dependence Washington, D.C. ~ April 13-16, 2003 Honorary Patient Recognition The Honorary Methadone Patient was developed by the National Alliance of Methadone Advocates to recognize those special persons who are not patients but in addition to making significant contributions to the field do so to help patients. Dr….

  • Complete Training

    Admin 08/05/2021

    Training for Certified Medication Assisted Treatment Advocate (CMA) National Alliance for Medication Assisted Recovery (NAMA Recovery) Complete Your Training You will need to mail in the CMA Test and Application to receive your certificate. If you have any questions contact: Walter Ginter Expired CMA’s Need to Recertify Pay for 2 Years of Membership and send…

  • Making Methadone Safe

    Admin 08/05/2022

    p3″ align=”center”>References American Association for the Treatment of Opiate Dependence. QTc Interval Screening – AATOD Policy and Guidance Statement (March 30, 2009). Available from AATOD, 225 Varick Street, New York, NY 10014. Black, L. DEA officials visit Waukegan clinic during probe of methadone death. Chicago Tribune (August 7, 2009). Omaha News Staff. Father Believes Son…

  • The Pharmacology of Opioids

    Admin 04/18/2023

    Basic Pharmacology:  How Methadone Works Part 2 Basic Opioid Pharmacology All natural and synthetic opioids exhibit a three dimensional T-shaped configuration (Barchas, Berger, Ciaranello and Elliott, 1977). This T-shaped molecule has two broad hydrophobic surfaces which are at right angles and a methylated nitrogen which is usually charged at physiological pH. The charged nitrogen is…

  • |

    Statement About MMT from NIDDK

    Admin 04/25/2022

    From NIDDK Fact Sheet Chronic Hepatitis C: Current Disease Management “Strict abstinence from alcohol is recommended during therapy with interferon. Interferon therapy can be associated with relapse in people with a previous history of drug or alcohol abuse. Therefore, alpha interferon should be given with caution to a patient who has only recently stopped alcohol…